BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Synthetic Blood International, Inc. 

Name change to Oxygen Biotherapeutics, Inc.
Press releases archived for reference only.
Costa Mesa  California    U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Medical Device






 Company News
Synthetic Blood International, Inc. (SYBD) Changes Name to Oxygen Biotherapeutics, Inc. 7/1/2008 10:28:35 AM
Synthetic Blood International, Inc. (SYBD) Shareholders Approve Name Change and Reincorporation 6/18/2008 10:19:49 AM
Synthetic Blood International, Inc. (SYBD) Acquires Exclusive License to Use New Virginia Commonwealth University Intellectual Property 5/23/2008 8:26:16 AM
Synthetic Blood International, Inc. (SYBD) Provides Updates On Phase II-B Clinical Trial Of Oxycyte; Additional Data Submitted End Of May 5/19/2008 8:41:51 AM
Synthetic Blood International, Inc. (SYBD) to Open New Research Office at Virginia BioTechnology Research Park 5/7/2008 8:45:14 AM
Synthetic Blood International, Inc. (SYBD) Comments on JAMA Article About Hemoglobin-Based Blood Substitutes 4/29/2008 8:52:29 AM
Synthetic Blood International, Inc. (SYBD) to Seek Shareholder Approval for Name Change 4/22/2008 8:49:32 AM
Synthetic Blood International, Inc. (SYBD) Announces Filing of Protocol for Phase II-b Oxycyte Clinical Trial 4/14/2008 9:03:49 AM
Synthetic Blood International, Inc. (SYBD) Announces Plans to File Protocol for Phase II-b Oxycyte(R) Clinical Trial 4/4/2008 8:36:53 AM
Synthetic Blood International, Inc. (SYBD) Announces New Leadership Roles to Continue Product Development Strategy 3/31/2008 9:20:33 AM
123456